Three Years of Daily BCI Use Rewrites the Timeline for Neural Interface Products
Casey Harrell's 3-year ALS speech BCI deployment is the most durable real-world neural interface result yet, pressuring Neuralink's consumer roadmap.
8. Three Years of Daily BCI Use Rewrites the Timeline for Neural Interface Products
Casey Harrell, a man living with ALS-related paralysis, has logged thousands of hours using a brain-computer interface to produce speech since a research team first activated the system in 2023. The implant uses electrodes embedded directly in the brain to decode intended speech and convert it to audible output. Published findings reported by MIT Technology Review on June 15, 2026, make Harrell the most documented long-term BCI user in the clinical record, with nearly three years of continuous deployment on a single implanted device.
That duration matters more than the headline capability. Most BCI demonstrations collapse within months: signal degradation, infection risk, and user fatigue have historically kept the technology in the proof-of-concept category. Harrell's case changes the evidentiary baseline. For Neuralink, which received FDA Breakthrough Device designation and implanted its first human patient in January 2024, this is both a data point and a pressure test. Neuralink has framed its N1 chip around motor restoration and communication for paralyzed users, the same target population. A competing research system now holds a longer continuous-use record. That gap will matter to the FDA reviewers, hospital procurement committees, and institutional review boards that control Neuralink's path to broader trials. Synchron, which takes a less invasive endovascular approach and has its own multi-year patient data, faces the same recalibration: raw longevity is now a competitive variable, not just a safety checkbox.
The broader pattern is a shift from "can it work" to "how long does it hold." The next data points to watch: whether Harrell's signal quality metrics at month 36 are published in a peer-reviewed journal, and how Neuralink's 2025 cohort reports compare on equivalent duration. The race for durable neural interfaces has a new benchmark.
Source: This man with ALS is "the first power user" of a brain implant that lets him speak